Overview
- Belliard detailed a plan for two additional fixed facilities and four mobile units to expand harm-reduction capacity in Paris.
- He identified Rosa-Parks, Stalingrad and the broader northeast of the city as priority zones for deployment.
- Paris currently operates a single HSA near Gare du Nord and Lariboisière hospital, which he says handles about 300 visits per day.
- He contends the existing site has eased neighborhood pressures, citing roughly a 30% drop in syringes found on the streets and support that connects users to care.
- Lawmakers voted to continue the national HSA experiment through 2027 with Health Minister Stéphanie Rist’s positive opinion, and a government report is expected for Parliament.